Everand Logo

Welcome to Everand!

  • STAT

    Pharma tries to cash in on migraine market by making new drugs free, for now

    With intense competition in the market for new migraine headache drugs, some companies are making their medicines free to patients with private insurance.
    by Damian Garde Sep 28, 2018 2 minutes

    With approval of a new migraine therapy, Eli Lilly has become the third drug company angling for dominance in what could become a multibillion-dollar market for preventing debilitating headaches. But because none of the three medicines is clearly better than another, the contenders are taking a novel approach to competition: giving drugs away for free.

    Lilly’s treatment, called Emgality, is an

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
    Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
    STAT1 min read
    STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
    A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
    STAT2 min readCrime & Violence
    STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
    A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

    Related